James Wang
17Patents
5h-index
83Co-inventors
69Inventor score
Filing activity: Apr 26, 1995 → Apr 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6372747B1 | Farnesyl protein transferase inhibitors | Chemistry; Metallurgy | 35 | Expired |
| US6225322A | Compounds useful for inhibition of farnesyl protein transferase | Chemistry; Metallurgy | 16 | Expired |
| US7807672B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 14 | Active |
| US9242981B2 | Fused pyrazole derivatives as novel ERK inhibitors | Chemistry; Metallurgy | 8 | Active |
| US9718828B2 | BTK Inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8546404B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 5 | Active |
| US5925648A | Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase | Chemistry; Metallurgy | 5 | Expired |
| US7557107B2 | Farnesyl protein transferase inhibitors as antitumor agents | Human Necessities | 2 | Active |
| US11078477B2 | Automated isolation and chemical reaction(s) of nucleic acids | Physics | 2 | Active |
| US7342016B2 | Farnesyl protein transferase inhibitors as antitumor agents | Chemistry; Metallurgy | 2 | Expired |
| US5739104A | Anti-fungal agents | Human Necessities | 1 | Expired |
| US8999966B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8716483B2 | Compounds that are ERK inhibitors | Human Necessities | 1 | Active |
| US11840739B2 | Gene composition for detecting cell proliferative abnormality or grading disease degree and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10968486B2 | Gene composition for detecting cell proliferative abnormality or grading disease degree and use thereof | Chemistry; Metallurgy | 0 | Active |
| US6740661B2 | Farnesyl protein transferase inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US7425640B2 | Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.